Cargando…

Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing

Process analytical technology (PAT) has demonstrated huge potential to enable the development of improved biopharmaceutical manufacturing processes by ensuring the reliable provision of quality products. However, the complexities associated with the manufacture of advanced therapy medicinal products...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Thomas, Kalinka, Kevin, Sanches, Rui, Blanchard-Emmerson, Greg, Watts, Samuel, Davies, Lee, Knevelman, Carol, McCloskey, Laura, Jones, Peter, Mitrophanous, Kyriacos, Miskin, James, Dikicioglu, Duygu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842697/
https://www.ncbi.nlm.nih.gov/pubmed/36646795
http://dx.doi.org/10.1038/s41598-023-27998-2
_version_ 1784870201017237504
author Williams, Thomas
Kalinka, Kevin
Sanches, Rui
Blanchard-Emmerson, Greg
Watts, Samuel
Davies, Lee
Knevelman, Carol
McCloskey, Laura
Jones, Peter
Mitrophanous, Kyriacos
Miskin, James
Dikicioglu, Duygu
author_facet Williams, Thomas
Kalinka, Kevin
Sanches, Rui
Blanchard-Emmerson, Greg
Watts, Samuel
Davies, Lee
Knevelman, Carol
McCloskey, Laura
Jones, Peter
Mitrophanous, Kyriacos
Miskin, James
Dikicioglu, Duygu
author_sort Williams, Thomas
collection PubMed
description Process analytical technology (PAT) has demonstrated huge potential to enable the development of improved biopharmaceutical manufacturing processes by ensuring the reliable provision of quality products. However, the complexities associated with the manufacture of advanced therapy medicinal products have resulted in a slow adoption of PAT tools into industrial bioprocessing operations, particularly in the manufacture of cell and gene therapy products. Here we describe the applicability of a novel refractometry-based PAT system (Ranger system), which was used to monitor the metabolic activity of HEK293T cell cultures during lentiviral vector (LVV) production processes in real time. The PAT system was able to rapidly identify a relationship between bioreactor pH and culture metabolic activity and this was used to devise a pH operating strategy that resulted in a 1.8-fold increase in metabolic activity compared to an unoptimised bioprocess in a minimal number of bioreactor experiments; this was achieved using both pre-programmed and autonomous pH control strategies. The increased metabolic activity of the cultures, achieved via the implementation of the PAT technology, was not associated with increased LVV production. We employed a metabolic modelling strategy to elucidate the relationship between these bioprocess level events and HEK293T cell metabolism. The modelling showed that culturing of HEK293T cells in a low pH (pH 6.40) environment directly impacted the intracellular maintenance of pH and the intracellular availability of oxygen. We provide evidence that the elevated metabolic activity was a response to cope with the stress associated with low pH to maintain the favourable intracellular conditions, rather than being indicative of a superior active state of the HEK293T cell culture resulting in enhanced LVV production. Forecasting strategies were used to construct data models which identified that the novel PAT system not only had a direct relationship with process pH but also with oxygen availability; the interaction and interdependencies between these two parameters had a direct effect on the responses observed at the bioprocess level. We present data which indicate that process control and intervention using this novel refractometry-based PAT system has the potential to facilitate the fine tuning and rapid optimisation of the production environment and enable adaptive process control for enhanced process performance and robustness.
format Online
Article
Text
id pubmed-9842697
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98426972023-01-18 Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing Williams, Thomas Kalinka, Kevin Sanches, Rui Blanchard-Emmerson, Greg Watts, Samuel Davies, Lee Knevelman, Carol McCloskey, Laura Jones, Peter Mitrophanous, Kyriacos Miskin, James Dikicioglu, Duygu Sci Rep Article Process analytical technology (PAT) has demonstrated huge potential to enable the development of improved biopharmaceutical manufacturing processes by ensuring the reliable provision of quality products. However, the complexities associated with the manufacture of advanced therapy medicinal products have resulted in a slow adoption of PAT tools into industrial bioprocessing operations, particularly in the manufacture of cell and gene therapy products. Here we describe the applicability of a novel refractometry-based PAT system (Ranger system), which was used to monitor the metabolic activity of HEK293T cell cultures during lentiviral vector (LVV) production processes in real time. The PAT system was able to rapidly identify a relationship between bioreactor pH and culture metabolic activity and this was used to devise a pH operating strategy that resulted in a 1.8-fold increase in metabolic activity compared to an unoptimised bioprocess in a minimal number of bioreactor experiments; this was achieved using both pre-programmed and autonomous pH control strategies. The increased metabolic activity of the cultures, achieved via the implementation of the PAT technology, was not associated with increased LVV production. We employed a metabolic modelling strategy to elucidate the relationship between these bioprocess level events and HEK293T cell metabolism. The modelling showed that culturing of HEK293T cells in a low pH (pH 6.40) environment directly impacted the intracellular maintenance of pH and the intracellular availability of oxygen. We provide evidence that the elevated metabolic activity was a response to cope with the stress associated with low pH to maintain the favourable intracellular conditions, rather than being indicative of a superior active state of the HEK293T cell culture resulting in enhanced LVV production. Forecasting strategies were used to construct data models which identified that the novel PAT system not only had a direct relationship with process pH but also with oxygen availability; the interaction and interdependencies between these two parameters had a direct effect on the responses observed at the bioprocess level. We present data which indicate that process control and intervention using this novel refractometry-based PAT system has the potential to facilitate the fine tuning and rapid optimisation of the production environment and enable adaptive process control for enhanced process performance and robustness. Nature Publishing Group UK 2023-01-16 /pmc/articles/PMC9842697/ /pubmed/36646795 http://dx.doi.org/10.1038/s41598-023-27998-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Williams, Thomas
Kalinka, Kevin
Sanches, Rui
Blanchard-Emmerson, Greg
Watts, Samuel
Davies, Lee
Knevelman, Carol
McCloskey, Laura
Jones, Peter
Mitrophanous, Kyriacos
Miskin, James
Dikicioglu, Duygu
Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
title Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
title_full Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
title_fullStr Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
title_full_unstemmed Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
title_short Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
title_sort machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842697/
https://www.ncbi.nlm.nih.gov/pubmed/36646795
http://dx.doi.org/10.1038/s41598-023-27998-2
work_keys_str_mv AT williamsthomas machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT kalinkakevin machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT sanchesrui machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT blanchardemmersongreg machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT wattssamuel machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT davieslee machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT knevelmancarol machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT mccloskeylaura machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT jonespeter machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT mitrophanouskyriacos machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT miskinjames machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing
AT dikiciogluduygu machinelearningandmetabolicmodellingassistedimplementationofanovelprocessanalyticaltechnologyincellandgenetherapymanufacturing